MedPath

Clinical Trial for Diabetic Foot Ulcer through Siddha medicines

Phase 2
Conditions
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Registration Number
CTRI/2023/10/058661
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Known case of type II DM with DFU

1 Age 30 to 65 years

2 Sex Males and Females

3 HbA1c level ranges from 8 to 14 percent

4 Patients taking medications (Integrated medicines or Allopathic) for DM II

5 Patient with Grading I and II of Wagners classification tool will be included in the

study

6 Patient who are willing to participate in the trial will be included

Exclusion Criteria

1 Patient with any signs and symptoms of Osteomyelitis

2 Ulcer with signs of gangrene

3 Known case of Varicose Ulcer

4 Ulcer in which bone and joints are involved

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 To observe the changes as per Wagners classification tool and Photostatic wound <br/ ><br>assessment scale for Diabetic Foot ulcer from baseline to end of the treatment <br/ ><br>Timepoint: 1 YEAR
Secondary Outcome Measures
NameTimeMethod
To observe the changes in the lab investigations from baseline to end of the treatmentTimepoint: 1 YEAR
© Copyright 2025. All Rights Reserved by MedPath